Prazitel Plus 50 mg / 144 mg / 150 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

prazitel plus 50 mg / 144 mg / 150 mg tabletti

chanelle pharmaceuticals manufacturing limited - febantel, praziquantel, pyrantel embonate - tabletti - 50 mg / 144 mg / 150 mg - pratsikvanteeli

Bcg Vaccine Ajvaccines injektiokuiva-aine ja liuotin, suspensiota varten Suomi - suomi - Fimea (Suomen lääkevirasto)

bcg vaccine ajvaccines injektiokuiva-aine ja liuotin, suspensiota varten

aj vaccines a/s - mycobacterium lehmä bcg (tanskalainen kanta 1331), elävä heikennetty - injektiokuiva-aine ja liuotin, suspensiota varten - tuberkuloosirokote

LIGOSLO 140 mg/g geeli ientaskuun Suomi - suomi - Fimea (Suomen lääkevirasto)

ligoslo 140 mg/g geeli ientaskuun

kulzer gmbh - doxycyclini hyclas - geeli ientaskuun - 140 mg/g - doksisykliini

Butasal vet 100 mg/ml + 0,05 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

butasal vet 100 mg/ml + 0,05 mg/ml injektioneste, liuos

interchemie werken de adelaar eesti as - cyanocobalamin, butafosfan - injektioneste, liuos - 100 mg/ml + 0,05 mg/ml

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Euroopan unioni - suomi - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - immunosuppressantit - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) on tarkoitettu aikuisille potilaille, joilla on aiemmin hoitamaton multippeli myelooma, jotka eivät ole oikeutettuja siirto. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 ja 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) on tarkoitettu aikuisille potilaille, joilla on aiemmin hoitamaton multippeli myelooma, jotka eivät ole oikeutettuja siirto. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 ja 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Panadol Pore 500 mg poretabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

panadol pore 500 mg poretabletti

haleon denmark aps - paracetamol - poretabletti - 500 mg - parasetamoli

Panadol 125 mg peräpuikko Suomi - suomi - Fimea (Suomen lääkevirasto)

panadol 125 mg peräpuikko

haleon denmark aps - paracetamol - peräpuikko - 125 mg - parasetamoli

Panadol 250 mg peräpuikko Suomi - suomi - Fimea (Suomen lääkevirasto)

panadol 250 mg peräpuikko

haleon denmark aps - paracetamol - peräpuikko - 250 mg - parasetamoli

Panadol 60 mg peräpuikko Suomi - suomi - Fimea (Suomen lääkevirasto)

panadol 60 mg peräpuikko

haleon denmark aps - paracetamol - peräpuikko - 60 mg - parasetamoli

Panapar 500 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

panapar 500 mg tabletti, kalvopäällysteinen

haleon denmark aps - paracetamol - tabletti, kalvopäällysteinen - 500 mg - parasetamoli